Menopausal-type symptoms among breast cancer patients on aromatase inhibitor therapy

By Gallicchio L.  

Climacteric, Vol. 15, Iss. 4, 2012-08 ,pp. : 339-349

Informa Healthcare

Access to resources Recommend Favorite

Neoadjuvant therapy of endometrial cancer with the aromatase inhibitor letrozole: endocrine and clinical effects

By Berstein L.   Maximov S.   Gershfeld E.   Meshkova I.   Gamajunova V.   Tsyrlina E.   Larionov A.   Kovalevskij A.   Vasilyev D.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 105, Iss. 2, 2002-11 ,pp. : 161-165

Elsevier

Access to resources Recommend Favorite

Menopausal obesity – myth or fact?

By Milewicz A.   Tworowska U.   Demissie M.  

Climacteric, Vol. 4, Iss. 4, 2001-12 ,pp. : 273-283

Informa Healthcare

Access to resources Recommend Favorite

A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women

By Fisher S.A.   Reid R.L.   Van Vugt D.A.   Casper R.F.  

Fertility and Sterility, Vol. 78, Iss. 2, 2002-08 ,pp. : 280-285

Elsevier

Access to resources Recommend Favorite

Correlation of androgen receptors, aromatase, and 5- reductase in the human vagina with menopausal status

By Berman J.R.   Almeida F.G.   Jolin J.   Raz S.   Chaudhuri G.   Gonzalez-Cadavid N.F.  

Fertility and Sterility, Vol. 79, Iss. 4, 2003-04 ,pp. : 925-931

Elsevier

Access to resources Recommend Favorite